STOCK TITAN

[6-K] Kamada Ltd Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Kamada Ltd (KMDA) reported stronger operating results in a Form 6-K filing that includes a company presentation and unaudited consolidated financial statements as of June 30, 2025. The company disclosed 11% year-over-year top-line growth for the first six months and a 35% increase in profitability over the same period. Management also raised full-year profitability guidance. The filing attaches the presentation and the Inline XBRL financial documents for more detail.

Kamada Ltd (KMDA) ha comunicato risultati operativi migliori in un modulo Form 6-K contenente una presentazione aziendale e bilanci consolidati non revisionati al 30 giugno 2025. La società ha dichiarato una crescita del fatturato del 11% su base annua nei primi sei mesi e un incremento della redditività del 35% nello stesso periodo. Il management ha inoltre rivisto al rialzo le stime di redditività per l'intero esercizio. Nell'allegato sono disponibili la presentazione e i documenti finanziari Inline XBRL per i dettagli.

Kamada Ltd (KMDA) informó resultados operativos más sólidos en un Form 6-K que incluye una presentación de la compañía y estados financieros consolidados no auditados al 30 de junio de 2025. La empresa reveló un crecimiento de ingresos interanual del 11% en los primeros seis meses y un aumento de la rentabilidad del 35% en el mismo periodo. La dirección también incrementó la guía de rentabilidad para todo el año. En el archivo se adjuntan la presentación y los documentos financieros Inline XBRL con más detalles.

Kamada Ltd (KMDA)는 2025년 6월 30일 기준의 회사 프레젠테이션과 미감사 연결재무제표를 포함한 Form 6‑K 제출서류에서 영업 실적 개선을 보고했습니다. 회사는 상반기 전년 대비 매출이 11% 증가했고 같은 기간에 수익성이 35% 향상했다고 밝혔습니다. 경영진은 또한 연간 수익성 전망을 상향 조정했습니다. 제출서류에는 상세 정보를 위한 프레젠테이션과 Inline XBRL 재무문서가 첨부되어 있습니다.

Kamada Ltd (KMDA) a déclaré des résultats opérationnels plus solides dans un formulaire 6‑K incluant une présentation de l'entreprise et des états financiers consolidés non audités au 30 juin 2025. La société a indiqué une croissance du chiffre d'affaires de 11% en glissement annuel sur les six premiers mois et une hausse de la rentabilité de 35% sur la même période. La direction a également relevé ses prévisions de rentabilité pour l'année. La pièce jointe contient la présentation et les documents financiers Inline XBRL pour plus de détails.

Kamada Ltd (KMDA) berichtete in einer Form 6‑K‑Einreichung, die eine Unternehmenspräsentation und ungeprüfte konsolidierte Abschlüsse zum 30. Juni 2025 enthält, über stärkere operative Ergebnisse. Das Unternehmen gab ein Jahresumsatzwachstum von 11% in den ersten sechs Monaten sowie eine 35%ige Steigerung der Profitabilität im gleichen Zeitraum bekannt. Das Management hat außerdem die Jahresprognose für die Profitabilität angehoben. Der Einreichung sind die Präsentation und die Inline‑XBRL‑Finanzdokumente für weitere Details beigefügt.

Positive
  • 11% year-over-year top-line growth for the first six months, indicating revenue momentum
  • 35% increase in profitability year-over-year for the six-month period, showing improved margins or operating leverage
  • Management raised full-year profitability guidance, signaling increased confidence in near-term performance
  • Unaudited consolidated financial statements as of June 30, 2025 and company presentation are attached for investor review
Negative
  • None.

Insights

TL;DR: Strong H1 revenue and profit growth with guidance uplift suggests improving operating leverage.

The disclosed 11% H1 revenue growth and 35% profitability increase are material positive signals for a specialized biopharma like Kamada, indicating accelerating demand or improved margins. The filing includes unaudited June 30, 2025 consolidated financials and a company presentation, enabling verification of line-item trends. Raising full-year profitability guidance is a forward-looking management signal, though the 6-K itself does not provide underlying drivers, regional breakdowns, or exact guidance figures. Impact on valuation depends on absolute revenue base and sustainability of margin improvements.

TL;DR: Reported growth and profitability gain are meaningful; details in attached financials are needed to assess sustainability.

The announcement of 11% Y/Y top-line growth for six months and a 35% rise in profitability is noteworthy for assessing product demand and cost structure efficiency. Inclusion of unaudited consolidated statements allows inspection of product segments, R&D spend, and one-time items that could explain the profitability swing. The raised full-year profitability guidance reflects management confidence, but the 6-K does not quantify the revised guidance within the extracted text, so further review of the exhibits is required for a full assessment.

Kamada Ltd (KMDA) ha comunicato risultati operativi migliori in un modulo Form 6-K contenente una presentazione aziendale e bilanci consolidati non revisionati al 30 giugno 2025. La società ha dichiarato una crescita del fatturato del 11% su base annua nei primi sei mesi e un incremento della redditività del 35% nello stesso periodo. Il management ha inoltre rivisto al rialzo le stime di redditività per l'intero esercizio. Nell'allegato sono disponibili la presentazione e i documenti finanziari Inline XBRL per i dettagli.

Kamada Ltd (KMDA) informó resultados operativos más sólidos en un Form 6-K que incluye una presentación de la compañía y estados financieros consolidados no auditados al 30 de junio de 2025. La empresa reveló un crecimiento de ingresos interanual del 11% en los primeros seis meses y un aumento de la rentabilidad del 35% en el mismo periodo. La dirección también incrementó la guía de rentabilidad para todo el año. En el archivo se adjuntan la presentación y los documentos financieros Inline XBRL con más detalles.

Kamada Ltd (KMDA)는 2025년 6월 30일 기준의 회사 프레젠테이션과 미감사 연결재무제표를 포함한 Form 6‑K 제출서류에서 영업 실적 개선을 보고했습니다. 회사는 상반기 전년 대비 매출이 11% 증가했고 같은 기간에 수익성이 35% 향상했다고 밝혔습니다. 경영진은 또한 연간 수익성 전망을 상향 조정했습니다. 제출서류에는 상세 정보를 위한 프레젠테이션과 Inline XBRL 재무문서가 첨부되어 있습니다.

Kamada Ltd (KMDA) a déclaré des résultats opérationnels plus solides dans un formulaire 6‑K incluant une présentation de l'entreprise et des états financiers consolidés non audités au 30 juin 2025. La société a indiqué une croissance du chiffre d'affaires de 11% en glissement annuel sur les six premiers mois et une hausse de la rentabilité de 35% sur la même période. La direction a également relevé ses prévisions de rentabilité pour l'année. La pièce jointe contient la présentation et les documents financiers Inline XBRL pour plus de détails.

Kamada Ltd (KMDA) berichtete in einer Form 6‑K‑Einreichung, die eine Unternehmenspräsentation und ungeprüfte konsolidierte Abschlüsse zum 30. Juni 2025 enthält, über stärkere operative Ergebnisse. Das Unternehmen gab ein Jahresumsatzwachstum von 11% in den ersten sechs Monaten sowie eine 35%ige Steigerung der Profitabilität im gleichen Zeitraum bekannt. Das Management hat außerdem die Jahresprognose für die Profitabilität angehoben. Der Einreichung sind die Präsentation und die Inline‑XBRL‑Finanzdokumente für weitere Details beigefügt.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

 

For the Month of August 2025

 

Commission File Number 001-35948

 

Kamada Ltd.

(Translation of registrant’s name into English)

 

2 Holzman Street
Science Park, P.O. Box 4081
Rehovot 7670402
Israel
(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒          Form 40-F ☐

 

 

 

 

 

This Form 6-K is being incorporated by reference into the Registrant’s Form S-8 Registration Statements, File Nos. 333-192720, 333-207933, 333-215983, 333-222891, 333-233267 and 333-265866.

 

1

 

 

The following exhibits are attached:

 

99.1   Kamada Reports Strong Second Quarter and First Half 2025 Financial Results with 11% Year-Over-Year 6-Month Top Line Growth and a 35% Increase in Profitability; Raises Full-Year Profitability Guidance
     
99.2   Company’s Presentation – August 2025
     
99.3   Kamada Ltd’s Consolidated Financial Statements as of June 30, 2025 (Unaudited)
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 13, 2025 KAMADA LTD.
   
  By: /s/ Nir Livneh
   

Nir Livneh

Vice President General Counsel and
Corporate Secretary

 

3

 

 

EXHIBIT INDEX

 

EXHIBIT NO.   DESCRIPTION
99.1   Kamada Reports Strong Second Quarter and First Half 2025 Financial Results with 11% Year-Over-Year 6-Month Top Line Growth and a 35% Increase in Profitability; Raises Full-Year Profitability Guidance
     
99.2   Company’s Presentation – August 2025
     
99.3   Kamada Ltd’s Consolidated Financial Statements as of June 30, 2025 (Unaudited)
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

4

FAQ

What growth did Kamada (KMDA) report for the first half of 2025?

The filing states 11% year-over-year top-line growth for the first six months of 2025.

How much did Kamada's profitability change in H1 2025?

Kamada reported a 35% increase in profitability compared with the same period last year.

Did Kamada change its full-year outlook in this 6-K?

Yes. The company raised full-year profitability guidance according to the filing.

What supporting documents were included with the 6-K?

The 6-K attaches a company presentation and unaudited consolidated financial statements as of June 30, 2025, plus Inline XBRL exhibits.

Are exact revised guidance numbers provided in the extracted content?

No. The extracted text states guidance was raised but does not include the specific revised figures.
Kamada Ltd

NASDAQ:KMDA

KMDA Rankings

KMDA Latest News

KMDA Latest SEC Filings

KMDA Stock Data

392.18M
31.27M
7.2%
49.18%
0.09%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Rehovot